ProQR Therapeutics (PRQR) EPS (Weighted Average and Diluted) (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00% |
| Sep 30, 2025 | 43.72% |
| Jun 30, 2025 | 41.39% |
| Mar 31, 2025 | -97,740,423.54% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | -78.15% |
| Jun 30, 2024 | 75.66% |
| Mar 31, 2024 | -139,650,897.70% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 43.28% |
| Jun 30, 2023 | 54.25% |
| Mar 31, 2023 | -44,826,226.06% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | 7.81% |
| Jun 30, 2022 | 50.20% |
| Mar 31, 2022 | -271.68% |
| Dec 31, 2021 | 11.70% |
| Sep 30, 2021 | 35.05% |
| Jun 30, 2021 | 34.37% |
| Mar 31, 2021 | -249.39% |
| Dec 31, 2020 | 28.03% |
| Sep 30, 2020 | -88.87% |
| Jun 30, 2020 | 78.84% |
| Mar 31, 2020 | -273.57% |
| Dec 31, 2019 | -8.43% |
| Sep 30, 2019 | 29.83% |
| Jun 30, 2019 | 55.11% |
| Mar 31, 2019 | -231.15% |
| Dec 31, 2018 | -47.47% |
| Sep 30, 2018 | 37.48% |
| Jun 30, 2018 | -3,987,933.36% |
| Mar 31, 2018 | -100.00% |
| Dec 31, 2017 | 8,300,390.29% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | -153.03% |